About 1 in 20 to 1 in 6 people with multiple sclerosis (MS) may also have PTSD, which can make symptoms, work, and medical care harder and needs more attention.
Researchers reviewed studies about PTSD in people with MS and found that between 5% and 16% of people with MS have PTSD. It is not yet clear if this is higher than the number in people without MS. PTSD in people with MS seems linked to worse outcomes like more trouble at work, trouble getting health care, and possibly changes in MS measurements. Early data show that men and women with MS may have similar rates of PTSD, which is different from the general population where women usually have higher rates. The review says we need better studies to understand what causes PTSD in MS and which treatments work best.
People with MS and their caregivers should care because PTSD can make everyday life harder, like keeping a job, going to doctor visits, or managing MS symptoms. Think of PTSD like a loud alarm that keeps going off and makes it hard to focus on other health needs—treating it can help calm that alarm so MS care works better. Health care providers should know to ask about trauma and PTSD because treating it could improve overall care and daily functioning. Employers and support services may need to offer flexible options, like time off or telehealth, to help people with both MS and PTSD. Family members and friends can help by listening, encouraging professional help, and helping with practical tasks when stress is high.
The studies so far are limited and vary in how they measure PTSD, so the exact number (5%–16%) is uncertain. We do not yet know if PTSD causes worse MS outcomes or if the relationship goes the other way, so be cautious about assuming cause and effect. More research is needed to find the best treatments for PTSD in people with MS, so current care should be personalized and discussed with your health team.
AI-generated summary — for informational purposes only, not medical advice
12/31/2026
Learn how certain gut bacteria can worsen MS symptoms and what this means for treatment and daily li
Read More12/31/2026
Researchers found consistent gut bacteria differences in MS tied to disease type, treatment response
Read More10/1/2026
Study finds different brain cells use unique ways to survive low-energy states; this could inspire f
Read More9/1/2026
A small study found Ma/Ma2 antibodies can cause nerve-only symptoms often linked to cancer; testing
Read More9/1/2026
Long-term study shows ravulizumab greatly reduced relapses in AQP4+ NMOSD over 3+ years with expecte
Read More9/1/2026
Even without common antibodies, NMOSD can be severe and relapsing; early maintenance immune treatmen
Read MoreWhether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Multiple sclerosis (Houndmills, Basingstoke, England) often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.
However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.
By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.